These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2579887)

  • 21. Nodular lymphocyte predominance type of Hodgkin's disease is a B cell lymphoma.
    Poppema S; Timens W; Visser L
    Adv Exp Med Biol; 1985; 186():963-9. PubMed ID: 2931963
    [No Abstract]   [Full Text] [Related]  

  • 22. Monoclonal antibodies in the histopathological diagnosis of non-Hodgkin lymphomas.
    Meijer CJ; Willemze R; Mullink H; Henzen-Logmans SC; Van der Valk P
    Neth J Med; 1985; 28(3):138-41. PubMed ID: 3872419
    [No Abstract]   [Full Text] [Related]  

  • 23. Nature of non-B, non-T lymphomas: an immunohistological study on frozen tissues using monoclonal antibodies.
    Pallesen G; Beverley PC; Lane EB; Madsen M; Mason DY; Stein H
    J Clin Pathol; 1984 Aug; 37(8):911-8. PubMed ID: 6381546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies reactive with B-lymphocytes and histiocytes in paraffin sections.
    Okon E; Felder B; Epstein A; Lukes RJ; Taylor CR
    Cancer; 1985 Jul; 56(1):95-104. PubMed ID: 2408727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms.
    Arnold A; Cossman J; Bakhshi A; Jaffe ES; Waldmann TA; Korsmeyer SJ
    N Engl J Med; 1983 Dec; 309(26):1593-9. PubMed ID: 6417538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An immunohistological study of immunoglobulin content of primary central nervous system lymphomas.
    Taylor CR; Russell R; Lukes RJ; Davis RL
    Cancer; 1978 Jun; 41(6):2197-205. PubMed ID: 418869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HTLV-positive and -negative T-cell lymphomas. Morphological and immunohistochemical differences between European and HTLV-positive Japanese T-cell lymphomas.
    Lennert K; Kikuchi M; Sato E; Suchi T; Stansfeld AG; Feller AC; Hansmann ML; Müller-Hermelink HK; Gödde-Salz E
    Int J Cancer; 1985 Jan; 35(1):65-72. PubMed ID: 2578441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ki-1 lymphoma histologically mimicking Hodgkin's disease].
    Watanaba K; Naito M; Tanahashi N; Nara M; Kobayashi H; Shimbo T; Kojima M
    Nihon Naika Gakkai Zasshi; 1989 Jul; 78(7):964-5. PubMed ID: 2551983
    [No Abstract]   [Full Text] [Related]  

  • 29. State of the Art Symposium: flow cytometry in the diagnosis of lymphoproliferative disorders by fine-needle aspiration.
    Jorgensen JL
    Cancer; 2005 Dec; 105(6):443-51. PubMed ID: 16155944
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of histologic and immunologic heterogeneity of non-Hodgkin's lymphomas.
    Borowitz MJ; Croker BP; Metzgar RS
    Am J Pathol; 1981 Nov; 105(2):97-106. PubMed ID: 6170233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen preservation in infarcted lymphoid tissue. A novel approach to the infarcted lymph node using monoclonal antibodies effective in routinely processed tissues.
    Norton AJ; Ramsay AD; Isaacson PG
    Am J Surg Pathol; 1988 Oct; 12(10):759-67. PubMed ID: 3262314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes.
    Said JW; Stoll PN; Shintaku P; Bindl JM; Butmarc JR; Pinkus GS
    Am J Clin Pathol; 1989 May; 91(5):542-9. PubMed ID: 2785753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic techniques in the evaluation of lymphoma.
    Patterson SD
    Ultrastruct Pathol; 1985; 9(3-4):195-208. PubMed ID: 3937309
    [No Abstract]   [Full Text] [Related]  

  • 34. The spectrum of Leu-M1 staining in lymphoid and hematopoietic proliferations.
    Swerdlow SH; Wright SA
    Am J Clin Pathol; 1986 Mar; 85(3):283-8. PubMed ID: 2428238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue immunomicroscopic evaluation of monoclonality of B-cell lymphomas: comparison with cell suspension studies.
    Tubbs RR; Sheibani K; Weiss RA; Sebek BA; Deodhar SD
    Am J Clin Pathol; 1981 Jul; 76(1):24-8. PubMed ID: 6789669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant lymphomas.
    Tindle BH
    Am J Pathol; 1984 Jul; 116(1):119-74. PubMed ID: 6377907
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunocytological study of cutaneous malignant lymphomas. Classification (author's transl)].
    Souteyrand P; Thivolet J; Alario A; Schmitt D; Perrot H
    Dermatologica; 1978; 157(5):268-81. PubMed ID: 150348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The distribution of neoplastic and normal B-lymphoid cells in nodular lymphomas: use of an immunoperoxidase technique on frozen sections.
    Harris NL; Data RE
    Hum Pathol; 1982 Jul; 13(7):610-7. PubMed ID: 7044947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immuno-histological diagnosis of lymphoproliferative diseases by selected combinations of antisera and monoclonal antibodies.
    Janossy G; Thomas JA; Pizzolo G; Granger SM; McLaughlin J; Habeshaw JA; Stansfeld AG; Sloane J
    Br J Cancer; 1980 Aug; 42(2):224-42. PubMed ID: 6775656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.